Withania
Withania · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Withania is a versatile medicinal plant that has gained significant scientific attention for its potent anticancer activities. The therapeutic potential of this plant is primarily driven by its unique chemical constituents known as withanolides. Research focuses heavily on utilizing the plant's root to produce concentrated extracts, including specialized ethanol plant extracts. Recent advancements have even led to the development of innovative Withania-assisted bioengineered cobalt NPs for targeted treatment. These diverse preparations aim to combat various forms of cancer by leveraging the plant's natural biochemical properties.
- Synonyms
- Physaliastrum · Puneeria · 4 more
- Common names
- Not available
- Family
- Solanaceae
- Distribution
- Not available
- Plant Parts
- Root
Classification
Common Names
Withania is a diverse genus of plants that carries various regional and linguistic identities across the globe. In certain local contexts, it is recognized by the common name koisiot, reflecting its specific cultural significance. It is also frequently referred to as machovkovec, a name that highlights its presence in different botanical traditions. The genus finds further representation in East Asian terminology, where it is known as 睡茄屬 in Chinese. Additionally, it is identified as 가시꽈리속 within the Korean botanical lexicon, showcasing the plant's widespread linguistic reach.
Sources: Catalogue of Life (COL)
Synonyms
Withania is a genus that has historically been associated with several different botanical names due to shifting taxonomic classifications. Over time, researchers have identified various synonyms for the plant, including the names Archiphysalis and Hypnoticum. Other recognized nomenclatural variations include Opsago and Physaliastrum. Additionally, the term Physaloides has been utilized to describe members of this group in different scientific contexts. Understanding these various synonyms is essential for anyone navigating the complex history of its botanical identity.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Withania is a fascinating plant that belongs to the expansive kingdom Plantae. Within this vast biological realm, it is specifically classified under the class Equisetopsida. Its taxonomic journey continues through the order Solanales, showcasing its evolutionary connections. This plant is a prominent member of the family Solanaceae, a group known for its diverse botanical characteristics. Ultimately, it is defined by its unique identity within the genus Withania.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Solanales |
| Family | Solanaceae |
| Genus | Withania |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Withania exhibits a diverse geographical presence across the vast African continent. Within East Tropical Africa, the plant is prominently distributed throughout Kenya, Tanzania, and Uganda. Its reach also extends westward toward the Macaronesia region. Specifically, populations can be found thriving among the Canary Islands. Additionally, the species maintains a notable presence within the Cape Verde archipelago.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Withania stands out as a significant medicinal plant species within the diverse landscape of cancer research. Recent studies exploring phytochemical and phylogenetic perspectives have identified this genus as having high potency against a range of cancer cells. As part of a broader group of plants used for chemoprotection, it demonstrates promising anticancer activity. This therapeutic potential is often linked to the rich presence of phytochemicals found in such highly effective species. Consequently, Withania remains a key subject of interest for those investigating natural agents to combat devastating diseases.
Compounds
Conditions
Withania serves as a highly potent medicinal plant capable of treating various types of cancer cells. Beyond its anticancer properties, this species also plays a critical role in mitigating the effects of cobalt nanoparticles. Specifically, the use of Withania to assist in the bioengineering of cobalt nanoparticles helps promote shoot length and seedling development in plants like Zea mays. This biological assistance contrasts with the growth inhibition caused by bulk cobalt chloride, which the plant's presence helps to counteract. Consequently, Withania acts as a vital agent in managing the physiological responses to both cobalt nanoparticles and cobalt chloride.
Preparations
Withania is prepared as various forms of extracts, including crude water extracts and general plant extracts, to study their therapeutic potential. Specifically, Withania is prepared as ethanol plant extracts and methanolic extracts, both of which have demonstrated high antioxidant and phenolic content. The plant is also prepared as Withania-assisted bioengineered cobalt NPs, which can stimulate seedling development in species like Zea mays. These various preparations, whether as a standard extract or specialized nanoparticles, highlight the plant's diverse medicinal and agricultural applications.
Parts used
Withania somnifera, widely recognized as Ashwagandha, holds a prestigious position in Ayurvedic medicine due to the significant therapeutic properties found within its roots. These root tissues serve as the primary source of withanolides, which are the essential metabolites responsible for the plant's medicinal efficacy. Recent advancements in hairy root culture techniques have allowed for the industrial-scale accumulation of these valuable compounds by optimizing media compositions and elicitors. Beyond traditional uses, scientific investigations have demonstrated that extracts derived specifically from the Withania root possess potent cytotoxic effects against human malignant melanoma cells. Consequently, the strategic cultivation and extraction of these root components continue to be vital for both pharmaceutical innovation and cancer research.